𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of mizoribine for the treatment of Sjögren's syndrome: a multicenter open-label clinical trial

✍ Scribed by Shingo Nakayamada; Kazuyoshi Saito; Hisanori Umehara; Noriyoshi Ogawa; Takayuki Sumida; Satoshi Ito; Seiji Minota; Hiroyuki Nara; Hirobumi Kondo; Jun Okada; Tsuneyo Mimori; Hajime Yoshifuji; Hajime Sano; Naoaki Hashimoto; Susumu Sugai; Yoshiya Tanaka

Publisher
Springer
Year
2007
Tongue
English
Weight
262 KB
Volume
17
Category
Article
ISSN
1439-7595

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical and histologic evidence of sali
Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome
✍ J. Pijpe; J. M. Meijer; H. Bootsma; J. E. van der Wal; F. K. L. Spijkervet; C. G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 1 views

## Abstract ## Objective To assess the effect of rituximab (anti‐CD20 antibody) therapy on the (immuno)histopathology of parotid tissue in patients with primary Sjögren's syndrome (SS) and the correlation of histologic findings with the flow rate and composition of parotid saliva. ## Methods In